Lenvervimab (INN; development code GC1102) is a monoclonal antibody that is being investigated for hepatitis B. This drug is being developed by GC Pharma...
2 KB (116 words) - 14:23, 26 September 2023
(granulocyte antigen) diagnostic agent Lendalizumab mab humanized C5 Lenvervimab mab humanized hepatitis B surfage antigen hepatitis B Lenzilumab mab...
146 KB (4,507 words) - 05:10, 18 July 2025
(+cilgavimab)† Tuvirumab§ Chimeric Cosfroviximab Larcaviximab Porgaviximab Vilobelimab† Humanized Felvizumab§ Lenvervimab† Motavizumab† Palivizumab Suvizumab§...
25 KB (2,697 words) - 18:32, 22 July 2025